Salivary diagnostics of the novel coronavirus SARS-CoV-2 (COVID-19).

COVID-19 SARS-CoV-2 antibodies diagnosis saliva salivary diagnostics

Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Apr 2022
Historique:
revised: 25 10 2020
received: 25 04 2020
accepted: 28 10 2020
pubmed: 20 11 2020
medline: 24 3 2022
entrez: 19 11 2020
Statut: ppublish

Résumé

Laboratory testing for the SARS-CoV-2 virus and the consequent respiratory coronavirus disease 2019 (COVID-19) is categorized into methods that detect the viral presence and methods that detect antibodies produced in the host as a response to infection. Methods that detect viral presence into the host excretions measure current infection by SARS-CoV-2, whereas the detection of human antibodies exploited against SARS-CoV-2 evaluates the past exposure to the virus. This review provides a comprehensive overview for the use of saliva as a specimen for the detection of SARS-CoV-2, the methods for the salivary diagnostics utilized till very recently, and the arisen considerations for the diagnosis of COVID-19 disease. The major advantage of using saliva as a specimen for the detection of SARS-CoV-2 is that saliva collection is a non-invasive method which produces no discomfort to the patient and permits the patients to utilize home self-sampling techniques in order to protect health providers from the exposure to the pathogen. There is an urgent need to increase the active research for the detection of SARS-CoV-2 in the saliva because the non-invasive salivary diagnostics may provide a reliable and cost-effective method suitable for the fast and early detection of COVID-19 infection.

Identifiants

pubmed: 33211392
doi: 10.1111/odi.13729
pmc: PMC7753835
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

867-877

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Emerg Infect Dis. 2005 Jan;11(1):167
pubmed: 15714659
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
BMC Infect Dis. 2019 Jul 17;19(1):632
pubmed: 31315573
Oral Dis. 2022 Apr;28 Suppl 1:867-877
pubmed: 33211392
Int J Infect Dis. 2020 Aug;97:174-176
pubmed: 32437932
Front Cell Infect Microbiol. 2020 Sep 04;10:470
pubmed: 33014893
Clin Oral Investig. 2020 Apr;24(4):1619-1621
pubmed: 32078048
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1250-1255
pubmed: 29358368
Emerg Infect Dis. 2004 Sep;10(9):1550-7
pubmed: 15498155
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076
pubmed: 32172228
Clin Infect Dis. 2020 Dec 31;71(11):2939-2946
pubmed: 32562544
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
J Infect. 2020 Sep;81(3):e48-e50
pubmed: 32593658
Emerg Microbes Infect. 2020 Dec;9(1):1356-1359
pubmed: 32459137
Viruses. 2020 May 26;12(6):
pubmed: 32466458
Open Forum Infect Dis. 2020 Jun 07;7(6):ofaa210
pubmed: 32577428
Oral Oncol. 2020 Sep;108:104926
pubmed: 32718820
J Dent Res. 2010 Apr;89(4):389-94
pubmed: 20177131
Influenza Other Respir Viruses. 2019 Sep;13(5):429-437
pubmed: 31225704
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
New Microbiol. 2014 Oct;37(4):449-57
pubmed: 25387283
Microb Pathog. 2020 Jul;144:104177
pubmed: 32244041
J Infect. 2020 Aug;81(2):e145-e147
pubmed: 32504740
J Infect. 2020 Sep;81(3):e75-e78
pubmed: 32579988
Travel Med Infect Dis. 2020 Mar - Apr;34:101629
pubmed: 32179122
mBio. 2020 Mar 26;11(2):
pubmed: 32217609
Emerg Infect Dis. 2004 Jul;10(7):1213-9
pubmed: 15324540
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257
Cancer Epidemiol. 2016 Aug;43:112-8
pubmed: 27263493
J Med Virol. 2021 Jan;93(1):533-536
pubmed: 32621616
Clin Infect Dis. 2017 Sep 15;65(6):1026-1032
pubmed: 28520858
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Eur J Epidemiol. 2007;22(3):195-202
pubmed: 17356926
J Infect Dis. 2019 Apr 8;219(8):1234-1242
pubmed: 30517651
Viruses. 2019 Mar 02;11(3):
pubmed: 30832341
J Med Virol. 2020 May;92(5):512-517
pubmed: 32073157
Int J Oral Sci. 2020 Apr 17;12(1):11
pubmed: 32300101
Int J Biol Sci. 2020 Mar 15;16(10):1698-1707
pubmed: 32226287
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Biomed Res Int. 2020 Jan 3;2020:2032057
pubmed: 31998782
J Infect. 2020 Jul;81(1):e45-e50
pubmed: 32298676
PLoS One. 2019 Jan 2;14(1):e0208455
pubmed: 30601814
Lancet. 2020 Apr 4;395(10230):1101-1102
pubmed: 32247384
Diagn Microbiol Infect Dis. 2015 Jun;82(2):120-7
pubmed: 25801777
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
J Virol. 2011 Apr;85(8):4025-30
pubmed: 21289121
PLoS One. 2019 Jun 20;14(6):e0218456
pubmed: 31220138
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Biochem Biophys Res Commun. 2020 Feb 17;:
pubmed: 32081428
Emerg Infect Dis. 2004 Jul;10(7):1258-63
pubmed: 15324546
Int J Med Sci. 2018 May 22;15(8):823-831
pubmed: 30008593
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32636214
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
J Oral Microbiol. 2013;5:
pubmed: 23487566
Clin Infect Dis. 2021 Mar 15;72(6):1064-1066
pubmed: 32584972
AIDS Res Hum Retroviruses. 2004 Sep;20(9):972-88
pubmed: 15585085

Auteurs

Evangelia Michailidou (E)

Department of Oral Medicine and Maxillofacial Pathology, School of Dentistry, Aristotle University, Thessaloniki, Greece.

Athanasios Poulopoulos (A)

Department of Oral Medicine and Maxillofacial Pathology, School of Dentistry, Aristotle University, Thessaloniki, Greece.

Georgios Tzimagiorgis (G)

Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH